Mouse corticotropin-releasing factor receptor type 2α gene:: Isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids

被引:71
作者
Chen, A [1 ]
Perrin, M [1 ]
Brar, B [1 ]
Li, C [1 ]
Jamieson, P [1 ]
DiGruccio, M [1 ]
Lewis, K [1 ]
Vale, W [1 ]
机构
[1] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1210/me.2004-0300
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Effects of the corticotropin-releasing factor (CRF) family of peptides are mediated through activation of two receptors, CRF receptor (CRFR) 1 and CRFR2. Based on the homology between known mammalian CRFR genes, we have isolated a cDNA encoding the mouse CRFR2alpha (mCRFR2alpha) ortholog from brain. The isolated cDNA encodes a 411-amino acid protein with high identity to the rat (similar to97%) and human (similar to93%) receptors. Central and peripheral expression of mCRFR2alpha, determined by RT-PCR followed by Southern hybridization, revealed that mCRFR2alpha is restricted mainly to brain structures, with highest levels in the hypothalamus and olfactory bulb. In situ hybridization showed mCRFR2alpha localization in discrete brain regions, including the lateral septum and the ventromedial hypothalamus, whereas mCRFR2beta is found only in the choroid plexus. Binding and signaling of CRF-related ligands was studied using COS-M6 or HEK293T cells transiently transfected with mCRFR2alpha. Urocortins (Ucns) show different affinities for binding to mCRFR2alpha: Ucn 3 binds mCRFR2alpha with approximately 11-fold lower affinity than Ucn 2, which displays an affinity similar to Ucn 1 (similar to1 nM). Cyclase activation, determined by intracellular cAMP accumulation and cAMP response element-luciferase activity, showed no differences between CRFR2alpha and CRFR2beta in response to stimulation by Ucn 1, Ucn 2, and Ucn 3. Interestingly, Ucn 3 was less efficacious than Ucn 1 or Ucn 2 in activating MAPK (ERK1/2-p44/p42) via CRFR2alpha, but all three Ucns showed equivalent efficacy for activating MAPK through mCRFR2alpha. We found a significant reduction in hypothalamic mCRFR2alpha mRNA levels after acute and chronic restraint stress in mice. Hypothalamic mCRFR2alpha gene transcription in mice was inhibited by glucocorticoid administration and elevated by adrenalectomy. In addition, we demonstrated that the mCRFR2alpha gene is increased in the hypothalamus of the CRFR1-null compared with wild type mice. The predicted mCRFR2alpha promoter region was isolated and fused to a luciferase reporter gene and found to be decreased by glucocorticoids in a dose and time-dependent manner when transfected into CATH. a cells. Computer analysis revealed the presence of 23 putative half-palindromic glucocorticoid response element sequences within 2.4 kb of the mCRFR2alpha 5' flanking region. Elucidation of the structure and processing of the mCRFR2 gene and examination of the mCRFR2alpha gene regulation in various conditions will enable better understanding of the involvement of this receptor in the central response to stress in normal and transgenic mice models.
引用
收藏
页码:441 / 458
页数:18
相关论文
共 61 条
  • [1] AGUILERA G, 1983, J BIOL CHEM, V258, P8039
  • [2] CRF and CRF receptors: Role in stress responsivity and other behaviors
    Bale, TL
    Vale, WW
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 : 525 - 557
  • [3] Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
    Bale, TL
    Contarino, AB
    Smith, GW
    Chan, R
    Gold, LH
    Sawchenko, PE
    Koob, GF
    Vale, WW
    Lee, KF
    [J]. NATURE GENETICS, 2000, 24 (04) : 410 - 414
  • [4] Brar B.K., 2002, ENCY HORMONES RELATE, P313
  • [5] Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway
    Brar, BK
    Jonassen, AK
    Stephanou, A
    Santilli, G
    Railson, J
    Knight, RA
    Yellon, DM
    Latchman, DS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 8508 - 8514
  • [6] Urocortin-II and Urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart
    Brar, BK
    Jonassen, AK
    Egorina, EM
    Chen, A
    Negro, A
    Perrin, MH
    Mjos, OD
    Latchman, DS
    Lee, KF
    Vale, W
    [J]. ENDOCRINOLOGY, 2004, 145 (01) : 24 - 35
  • [7] Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides
    Brar, BK
    Chen, A
    Perrin, MH
    Vale, W
    [J]. ENDOCRINOLOGY, 2004, 145 (04) : 1718 - 1729
  • [8] CORTICOTROPIN-RELEASING FACTOR - ACTIONS ON THE SYMPATHETIC NERVOUS-SYSTEM AND METABOLISM
    BROWN, MR
    FISHER, LA
    SPIESS, J
    RIVIER, C
    RIVIER, J
    VALE, W
    [J]. ENDOCRINOLOGY, 1982, 111 (03) : 928 - 931
  • [9] Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: Identification of multiple splice variants
    Catalano, RD
    Kyriakou, T
    Chen, J
    Easton, A
    Hillhouse, EW
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (03) : 395 - 410
  • [10] CHALMERS DT, 1995, J NEUROSCI, V15, P6340